avatar University of Utah Health Hospitals and Clinics Services

Pages

  • Page 1

    THE CANCER CENTER OF THE WEST TM 2018 Report to Our Community


  • Page 2

    THE CANCER CENTER IN MEMORIAM OF THE WEST TM Each year, Huntsman Cancer Institute (HCI) compiles a Report to Our CONTENTS Community that looks back on the prior year’s accomplishments and signature events. And each year, Jon M. Huntsman Sr., our founder and benefactor, works CREATED BY HCI’S closely with us to determine which of many noteworthy achievements to feature. COMMUNICATIONS AND PUBLIC AFFAIRS TEAM Mr. Huntsman passed away at home on February 2, 2018, surrounded by his 4 LEADERSHIP Ashlee Bright, Director loving family. Tributes flowed in from around the world. MESSAGES Meredith Vehar, Associate Director The content in the enclosed report is just one of many projects we were working Lisa Anderson on with him prior to his passing. As a tribute to Mr. Huntsman, we present this Claire Davis report as a reflection of the stories he wanted to share about HCI, including a Diane Fouts message from his family, which begins on page 6. Alyssa Geisler Garrett Harding 10 EXPANDING HCI Jonathan Martinez Tonya Papanikolas Amie Parker Debby Rogers Amy Westberg Jill Woods 16 RESEARCH CONTRIBUTORS Jacqueline Brakey Susan Sheehan Diana Stafforini PRINTING 20 PATIENT CARE Printers Inc., with special thanks to Ron Petersen Thank you to all who support our mission, including patients and their families, donors, volunteers, 24 EDUCATION AND researchers, clinical care professionals, RECRUITMENT administrators, and Huntsman Cancer Foundation staff. @huntsmancancerinstitute In the words of Jon M. Huntsman: @huntsmancancerinstitute 27 GIVING Cancer moves fast. And we have to move faster. @huntsmancancer www.huntsmancancer.org View extended content at www.huntsmancancer.org/annualreport 2 3


  • Page 3

    Message from Our CEO and Director colon cancer, breast cancer, prostate cancer, and SENIOR LEADERSHIP ADDITIONAL CABINET MEMBERS childhood cancers, among others. Students come Mary Beckerle, PhD Neeraj Agarwal, MD to HCI to participate in our exemplary research HCI CHIEF EXECUTIVE OFFICER AND DIRECTOR DIRECTOR, HCI CENTER FOR INVESTIGATIONAL THERAPEUTICS and care programs that lead this next generation JON M. HUNTSMAN PRESIDENTIAL ENDOWED CHAIR DIRECTOR, GENITOURINARY MEDICAL ONCOLOGY PROGRAM to pursue bold, new strategies to confront cancer. DISTINGUISHED PROFESSOR OF BIOLOGY ASSOCIATE PROFESSOR, INTERNAL MEDICINE Established researchers and care providers come to HCI knowing they can practice their craft Bradley Cairns, PhD Michael Engel, MD, PhD at a state-of-the-art cancer campus, where “the HCI SENIOR DIRECTOR OF BASIC SCIENCE ASSOCIATE PROFESSOR, PEDIATRICS JON AND KAREN HUNTSMAN PRESIDENTIAL PROFESSOR patient first” is a principle that guides every IN CANCER RESEARCH aspect of what we do. N. Lynn Henry, MD, PhD CHAIR AND PROFESSOR, ONCOLOGICAL SCIENCES DIRECTOR, HCI BREAST MEDICAL ONCOLOGY PROGRAM The heartbeat of HCI’s mission emanates from ASSOCIATE PROFESSOR, INTERNAL MEDICINE Michael Deininger, MD, PhD four interconnected buildings nestled into the INTERIM DIVISION CHIEF, MEDICAL ONCOLOGY HCI SENIOR DIRECTOR OF TRANSDISCIPLINARY RESEARCH foothills of Salt Lake City. Thanks to Jon M. and M.M. WINTROBE PROFESSOR OF MEDICINE Karen Huntsman and an army of supporters, Grant Lasson, MBA PROFESSOR, INTERNAL MEDICINE CHIEF STRATEGY OFFICER every detail promotes synergy among researchers, CHIEF, DIVISION OF HEMATOLOGY AND HEMATOLOGIC MALIGNANCIES UNIVERSITY OF UTAH HEALTH fosters interaction between patients and staff, and provides comfort and healing to individuals David Gaffney, MD, PhD Courtney Scaife, MD and families affected by a cancer diagnosis. Our PROFESSOR, SURGERY HCI SENIOR DIRECTOR OF CLINICAL RESEARCH culture of collaboration is fundamental to our VICE CHAIR FOR CANCER AFFAIRS IN SURGERY J. ROBERT AND ANN K. STEWART ENDOWED PROFESSORSHIP ability to make discoveries and turn them into VICE-CHAIR AND PROFESSOR, RADIATION ONCOLOGY new strategies to defeat cancer. Dennis C. Shrieve, MD, PhD Scott Lloyd, MBA, CPA HCI CHAIR IN CANCER RESEARCH Our outreach to people affected by cancer PROFESSOR AND CHAIR, RADIATION ONCOLOGY HCI EXECUTIVE DIRECTOR OF OPERATIONS extends beyond our four beautiful buildings. Our commitment to patients who live far from HCI Theresa Werner, MD Martin McMahon, PhD endures, evident through our satellite clinics and HCI SENIOR DIRECTOR OF PRECLINICAL TRANSLATION MEDICAL DIRECTOR, HCI CLINICAL TRIALS OFFICE efforts to reach those in rural and frontier areas CUMMING ENDOWED CHAIR ASSOCIATE PROFESSOR, INTERNAL MEDICINE MARY BECKERLE, PHD by telemedicine. We promise people living within PROFESSOR, DERMATOLOGY the vast frontiers of the West that we will work tirelessly to offer them the same cancer screening John Sweetenham, MD THE WEST CONJURES UP IMAGES and monitoring services close to home that are HCI SENIOR DIRECTOR OF CLINICAL AFFAIRS AND EXECUTIVE MEDICAL DIRECTOR of miles of open land, exploration, and new available to patients living near our campus. PROFESSOR, INTERNAL MEDICINE frontiers—imagery that uniquely aligns with the mission of Huntsman Cancer Institute (HCI) to The West is known for its “can-do” spirit, for the willingness of our people to work together. Ben Tanner, MHA advance cutting-edge cancer research and care HCI CANCER HOSPITAL in our region. At HCI, we strive to push the boundaries of EXECUTIVE DIRECTOR cancer research and attain results beyond what we HCI patients come mostly from five states: thought possible. Cornelia Ulrich, PhD, MS Utah, Wyoming, Montana, Idaho, and Nevada. HCI SENIOR DIRECTOR OF They travel to HCI in search of hope, knowing HCI remains ever committed to continuing to POPULATION SCIENCES our care teams dedicate their careers to fighting be the Mountain West’s destination center for JON AND KAREN HUNTSMAN PRESIDENTIAL PROFESSOR IN CANCER RESEARCH cancer. By design, HCI’s research and clinical cancer research, education, and treatment. In this PROFESSOR, POPULATION HEALTH SCIENCES MESSAGES MESSAGES care programs have the best specialists and report, you will read a few highlights from the CHIEF, DIVISION OF CANCER equipment available to treat the cancers most past year—examples of our ongoing work to be POPULATION SCIENCES prevalent in this region, including melanoma, The Cancer Center of the West. HCI’S SENIOR LEADERSHIP TEAM 4 5


  • Page 4

    Message from the Jon M. Huntsman Family JON M. AND KAREN HUNTSMAN AT THE PRIMARY CHILDREN’S AND FAMILIES’ CANCER RESEARCH CENTER DEDICATION KRYSTAL PACE, INFUSION MEDICAL ASSISTANT, WITH PETER R. HUNTSMAN, CEO AND CHAIRMAN OF HUNTSMAN CANCER FOUNDATION JON M. HUNTSMAN AND HIS GRANDDAUGHTER, ABBY HUNTSMAN FOR OUR FAMILY, 2017 at Huntsman Cancer numerous childhood and adult cancers, including is in the hands of an excellent steward and Institute (HCI) was nothing short of spectacular. head, neck, and brain tumors, lymphomas, exceptional leader. We realized our dream to speed the development and pancreas, prostate, and esophageal cancers. Proton therapy is often the favored course We promise you that we will not rest until of better treatments with the dedication of the of treatment when a tumor is close to a vital cancer is eradicated from the face of the earth. new Primary Children’s and Families’ Cancer structure such as the spinal cord or brain. The Each generation of our family is steadfast in this Research Center on June 21, 2017. The new promise to our friends, neighbors, fellow citizens 225,000-square-foot building brings more equipment is very expensive—approximately UNIVERSITY OF UTAH AND HUNTSMAN CANCER FOUNDATION LEADERSHIP of Utah, the Mountain West, the United States, resources to fight this dreaded disease, it doubles $30 million. Huntsman Cancer Foundation will SIGN A NEW MEMORANDUM OF UNDERSTANDING OCTOBER 5, 2017 and the international community. That is why the laboratory research space, and it expands contribute $10 million toward the cost to make we have pledged to add $120 million in support services to help families overcome cancer. this treatment possible. Right now, the nearest HUNTSMAN CANCER FOUNDATION over the next eight years. BOARD OF DIRECTORS places to receive proton therapy are Los Angeles Since the founding of HCI, the pace of work, and Tucson. HCI’s plan to add proton therapy The successful performance of Huntsman the rate of building, and the new treatment CHIEF EXECUTIVE OFFICER AND illustrates that we will never rest on our laurels or Corporation stock we donated years ago provides CHAIRMAN OF THE BOARD advancements achieved have been breathtaking. previously earned accolades. strong financial footing for HCI’s future. Peter R. Huntsman Every recipient of this report has helped make It means other donations can go directly to this possible. We are very grateful to each of Speaking of accolades, our CEO and Director, BOARD OF DIRECTORS research and care, instead of paying for overhead you for sharing our passion to end the suffering Mary Beckerle, PhD, is the 2018 recipient of President Ruth V. Watkins and administrative costs. One donor alone is not caused by cancer. In all, more than 1 million the prestigious Alfred G. Knudson Award in A. Scott Anderson solely responsible for the success of HCI. Every people have donated to this effort. Thank you! Cancer Genetics from the National Cancer donor, member of our fine Huntsman Cancer Institute. The award has been presented for the PRESIDENT AND CHIEF OPERATING OFFICER Foundation team, and of course, our skilled Susan Sheehan Our family’s motto is, “Cancer moves fast. And past 22 years to the person who has made the researchers, physicians, and staff at HCI must be we have to move faster.” With that in mind, greatest contributions to the cancer genetics field. thanked for the progress we have made. CHIEF FINANCIAL OFFICER HCI has announced plans to add proton therapy Past recipients include four Nobel Laureates. Thomas E. Muir MESSAGES MESSAGES to its arsenal of treatment technologies. Proton To say we are proud of Dr. Beckerle is an Together, we are making spectacular things therapy delivers beams of radiation to shrink a understatement. With an accomplished leader happen at HCI. We are very grateful. SECRETARY tumor. It has proven to be an effective option for like her, you can be assured that your support Ronald G. Moffitt 6 7


  • Page 5

    Selected Awards and Honors SELECTED NATIONAL AWARDS AND HONORS Kevin Jones, MD (pictured bottom left) ASSOCIATE PROFESSOR, ORTHOPAEDICS Mary Beckerle, PhD ST. BALDRICK’S RESEARCH GRANT DISTINGUISHED PROFESSOR, BIOLOGY AMERICAN PHILOSOPHICAL SOCIETY INDUCTEE, 2017 Michelle Mendoza, PhD NATIONAL CANCER INSTITUTE ALFRED G. KNUDSON PRIZE IN ASSISTANT PROFESSOR, ONCOLOGICAL SCIENCES CANCER GENETICS, 2018 V FOUNDATION FOR CANCER RESEARCH V SCHOLAR GRANT Saundra Buys, MD (pictured top left) Eric Snyder, MD, PhD PROFESSOR, INTERNAL MEDICINE ASSISTANT PROFESSOR, PATHOLOGY FORBES’ PHYSICIAN HONOR ROLL FOR TOP BREAST CANCER PHYSICIANS, 2017 V FOUNDATION FOR CANCER RESEARCH V SCHOLAR GRANT Bradley Cairns, PhD (pictured top right) Cornelia Ulrich, PhD, MS PROFESSOR AND CHAIR, ONCOLOGICAL SCIENCES PROFESSOR, POPULATION HEALTH SCIENCES ELECTED AS AMERICAN ACADEMY OF ARTS AND SCIENCES NATIONAL INSTITUTES OF HEALTH U01 GRANT FELLOW, 2017 David Wetter, PhD Dana Carroll, PhD PROFESSOR, POPULATION HEALTH SCIENCES DISTINGUISHED PROFESSOR, BIOCHEMISTRY NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER ELECTED TO NATIONAL ACADEMY OF SCIENCES, 2017 MOONSHOT INITIATIVE TOBACCO CESSATION GRANT ELECTED AS AMERICAN ACADEMY OF ARTS AND SCIENCES FELLOW, 2017 SELECTED COLLABORATIVE GRANTS Martin McMahon, PhD Alana Welm, PhD, and Bryan Welm, PhD PROFESSOR, DERMATOLOGY DEPARTMENTS OF ONCOLOGICAL SCIENCES AND SURGERY AMERICAN SKIN ASSOCIATION LEADERSHIP IN MELANOMA RESEARCH AWARD, 2017 NATIONAL INSTITUTES OF HEALTH U54 GRANT Josef Prchal, MD Theresa Werner, MD, and Adam Cohen, MD PROFESSOR, INTERNAL MEDICINE DEPARTMENT OF INTERNAL MEDICINE HENRY M. STRATTON MEDAL FOR BASIC SCIENCE BY THE NATIONAL INSTITUTES OF HEALTH U54 GRANT AMERICAN SOCIETY OF HEMATOLOGY, 2017 OTHER NOTABLE AWARDS AND HONORS SELECTED NATIONAL LEADERSHIP POSITIONS Utah Construction and Design Magazine N. Lynn Henry, MD, PhD MOST OUTSTANDING HEALTHCARE PROJECT, 2017 ASSOCIATE PROFESSOR, INTERNAL MEDICINE THE PRIMARY CHILDREN’S AND FAMILIES’ CANCER RESEARCH 2018-2021 CHAIR-ELECT, AMERICAN SOCIETY FOR CLINICAL CENTER AT HUNTSMAN CANCER INSTITUTE ONCOLOGY NOMINATING COMMITTEE Salt Lake City Weekly Magazine Ana María López, MD, MPH (pictured bottom right) READERS’ POLL, JON M. HUNTSMAN SR. “BEST UTAHN,” 2017 PROFESSOR, INTERNAL MEDICINE ELECTED PRESIDENT OF THE AMERICAN COLLEGE OF Graphic Design USA PHYSICIANS, 2017 HEALTH + WELLNESS DESIGN AWARD, 2017 “IMAGINE ME, TOBACCO FREE” HUNTSMAN CANCER INSTITUTE TOBACCO QUIT GUIDE BOOKLET SELECTED NOTABLE GRANTS Michael Deininger, MD, PhD PROFESSOR, INTERNAL MEDICINE V FOUNDATION FOR CANCER RESEARCH TRANSLATIONAL GRANT Michael Engel, MD, PhD MESSAGES MESSAGES ASSOCIATE PROFESSOR, PEDIATRICS V FOUNDATION FOR CANCER RESEARCH PEDIATRIC TRANSLATIONAL GRANT 8 9


  • Page 6

    New Primary Children’s and Families’ Cancer Research Center at HCI IN CELEBRATION OF THE OPENING of the Primary Children’s and Families’ Cancer Research Center at HCI, a symposium called “Frontiers in Cancer Prevention, Research, and Therapy” took place in September 2017. Approximately 330 people attended the symposium, which featured eight lectures by international leaders in cancer research and a poster session where HCI students, fellows, and faculty highlighted their work. SYMPOSIUM SPEAKERS Robert T. Croyle, PhD DIRECTOR, DIVISION OF CANCER CONTROL AND POPULATION SCIENCES ANDREW VAN WAGONER PRESENTED A DONATION OF $119 FOR CANCER RESEARCH TO JON M. HUNTSMAN SR. WHILE PETER HUNTSMAN AND NATIONAL CANCER INSTITUTE JON HUNTSMAN JR. LOOKED ON. ANDREW COLLECTED CONTRIBUTIONS BY GOING DOOR TO DOOR IN HIS NEIGHBORHOOD. Ralph DeBerardinis, MD, PhD CHIEF, DIVISION OF PEDIATRIC GENETICS AND METABOLISM CHILDREN’S MEDICAL CENTER RESEARCH INSTITUTE STAYING AT THE FOREFRONT OF CANCER RESEARCH AND PATIENT CARE is a core PROFESSOR, PEDIATRICS, UT SOUTHWESTERN MEDICAL CENTER value of Huntsman Cancer Institute (HCI). That’s why HCI has invested in attracting top researchers and Raymond N. DuBois, MD, PhD medical professionals and building world-class facilities. INVESTIGATOR, HOLLINGS CANCER CENTER DEAN, COLLEGE OF MEDICINE, MEDICAL UNIVERSITY OF SOUTH CAROLINA In June 2017, HCI opened a new 225,000-square-foot expansion, doubling its research capacity. The Judy E. Garber, MD, MPH new Primary Children’s and Families’ Cancer Research Center provides the foundation for advances in DIRECTOR, CENTER FOR CANCER GENETICS AND PREVENTION DANA-FARBER CANCER INSTITUTE understanding childhood cancers. It will also trace familial cancers and accelerate the development of new PROFESSOR, MEDICINE, HARVARD MEDICAL SCHOOL treatments and cancer prevention strategies. Enhancements include a Biotechnology Center, with the Guillermina (Gigi) Lozano, PhD latest genetic sequencing and imaging equipment. PROFESSOR AND CHAIR, GENETICS UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER “This new research space is essential to HCI’s mission to relieve the suffering of cancer patients through Sean Morrison, PhD understanding cancer,” said Mary Beckerle, PhD, CEO and director. “By bringing together the most DIRECTOR, CHILDREN’S MEDICAL CENTER RESEARCH INSTITUTE innovative scientific minds with leading-edge technologies, we will accelerate cancer research discovery.” PROFESSOR AND CHAIR, PEDIATRIC GENETICS UT SOUTHWESTERN MEDICAL CENTER INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE Principal support for the $116.7 million expansion (not including financial costs) was provided by the Jon M. Huntsman family, Huntsman Cancer Foundation, the Church of Jesus Christ of Latter-day Saints, Antoni Ribas, MD, PhD DIRECTOR, TUMOR IMMUNOLOGY PROGRAM Intermountain Healthcare, and the State of Utah. JONSSON COMPREHENSIVE CANCER CENTER PROFESSOR, MEDICINE, SURGERY, MOLECULAR AND MEDICAL PHARMACOLOGY This addition marked HCI’s fourth major construction phase. The first phase, the Jon M. Huntsman UNIVERSITY OF CALIFORNIA, LOS ANGELES Cancer Research Center, was completed in 1999, and comprises 231,000 square feet with three floors of Martine Roussel, PhD EXPANDING EXPANDING research labs and a floor of outpatient clinics. The second phase, a 286,000-square-foot cancer specialty ENDOWED CHAIR IN MOLECULAR ONCOGENESIS ST. JUDE CHILDREN’S RESEARCH HOSPITAL hospital with 50 inpatient rooms, opened in 2004. In the fall of 2011, a major expansion of the cancer PROFESSOR, MOLECULAR SCIENCES, UNIVERSITY OF TENNESSEE, MEMPHIS hospital opened, which doubled clinical capacity. 10 11


  • Page 7

    Expanding Access: Highlights from Our Catchment Area PAT I E N T S P O T L I G H T: R E B E C C A W A R D AS A NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER, Huntsman Cancer Institute (HCI) has placed an emphasis on working to expand access to cancer care, research, and education to all who live in our catchment area. This means pursuing care approaches to meet the needs of patients who live in major cities as well as rural areas, and patients who are young or very elderly. It also includes providing training for the next generation of cancer researchers. These are just a few highlights of how we are working to expand access as the Cancer Center of the West. RESEARCH HIGHLIGHTS • A study led by Mia Hashibe, PhD, associate professor of family and preventive medicine, shows risk for aging-related diseases such as heart disease and diabetes are significantly higher among people diagnosed with thyroid cancer before age 40. Published in the journal Cancer Epidemiology, Biomarkers, and Prevention. • Research led by Matthew Poppe, MD, associate professor of radiation oncology, found that a shorter course of radiation (three weeks instead of the standard six) may be a safe, more convenient option for women with breast cancer after mastectomy, meaning less time away from home and lower out-of-pocket health care costs. Published in the Journal of Clinical Oncology. CLINICAL CARE HIGHLIGHTS • Now offering clinical trials at HCI’s South Jordan and OUR LOCATIONS Farmington clinics AFFILIATE HOSPITALS Carson City, Nevada; Rexburg, Idaho; Jackson and • Working with affiliate hospitals across the Mountain Rock Springs, Wyoming; Grand Junction, Colorado West to expand cancer genetic counseling, bone HUNTSMAN-INTERMOUNTAIN CANCER EDUCATION FACILITIES marrow transplant care, and clinical trials Logan, Ogden, Salt Lake City, Murray, Provo, American Fork, Cedar City, St. George REBECCA WARD AND HER HUSBAND, CURTIS EDUCATION HIGHLIGHTS Most people don’t think of routine dental cleaning as a life-saver, but Rebecca • PathMaker Summer Research Program: Ward from Idaho Falls, Idaho, does. Rebecca’s hygienist saw a suspicious Engages diverse students to learn in sore on her tongue. It turned out to be oral cancer, although Rebecca had never used tobacco or alcohol—two major factors that increase the risk for HCI research labs and explore HCI at Farmington this disease. The Head and Neck Cancers team at Huntsman Cancer Institute careers in cancer research, medicine, Health Center HCI at the removed the tumor and reconstructed Rebecca’s tongue with skin and fat and health HCI at South University of Utah from her arm. Jordan Health Center • Geographic Management of Cancer An oral cancer like Rebecca’s can have devastating effects on a person’s Health Disparities Program (GMaP): swallowing and speech if not treated promptly. But fortunately, Rebecca’s Supports research and understanding to surgery was a success and she can still speak. Now she uses her voice to improve access throughout Idaho, Montana, warn others about cancer prevention and regular oral screenings. Nevada, North Dakota, South Dakota, EXPANDING EXPANDING Wyoming, and Utah 12 13


  • Page 8

    Navigating Cancer at a Young Age Encouraging Lifelong Cancer Prevention in Youth It is known that more than 50% of cancer cases can be prevented by living a healthy lifestyle: avoiding tobacco, practicing sun safety, eating healthy foods, exercising, getting vaccinations, and being screened for cancer. These personal behavior choices are often difficult to practice, especially at a young age. Through community partnerships, Huntsman Cancer Institute (HCI) is reaching adolescent and young adult (AYA) populations where they are—in schools, neighborhoods, and communities—with an educational recipe for a lifetime of healthy living. Here are two examples. The SUN Study In 2017, Yelena Wu, PhD, a psychologist and HCI investigator, collaborated with health educators and school districts to provide skin cancer education to more than 1,500 rural and urban high school students throughout Utah, the state with the highest rate of melanoma. The Skin Cancer UNderstanding in Utah High Schools (SUN) Study, which includes hands-on activities and SAMANTHA PANNIER, ANNE KIRCHHOFF, PHD, DONNA BRANSON, surveys, will provide new information about effective SARA SALMON, AND R. LOR RANDALL, MD, WITH THE HI-AYA PROGRAM strategies to change AYA skin cancer prevention behaviors in this vulnerable population. EACH YEAR, MORE THAN 1,000 ADOLESCENTS and young adults (AYAs) in Utah are diagnosed with cancer. For many of these young people, age 15-39, a cancer diagnosis Boy Scouts of America Safety Moment is their first real medical issue. Patients may suddenly have to learn the difference between a More than 136 merit badges are offered by the Boy medical oncologist and a radiation oncologist. Scouts of America (BSA) and at least 47 of them They may also have questions about future involve outdoor activities with potential for sun fertility issues or need help understanding the exposure. Seeing an opportunity to promote sun safety health care system. This was the case for Marina in this at-risk population, HCI partnered with the BSA Pimentel, who was diagnosed with Hodgkin MARINA PIMENTEL AND HER HUSBAND, KENT Greater Salt Lake Council to create a Safety Moment lymphoma, a type of blood cancer, at age 26. that reached approximately 205,000 scouts and 68,000 scout leaders locally. The graphic encourages sun-safe Marina worked with Huntsman Cancer Institute Through the HI-AYA Program, patient behavior in all Scouting adventures and can be found at the University of Utah and Intermountain navigators work with and connect patients with online at www.scouting.org. Healthcare’s Huntsman-Intermountain information and resources. Navigators support EXPANDING EXPANDING Adolescent and Young Adult (HI-AYA) Program AYA patients throughout their cancer diagnosis, to help her manage the complexities of cancer treatment, recovery, and beyond. Learn more: treatment and care. www.huntsmancancer.org/hiaya 14 15


  • Page 9

    Developing Better Targeted Therapies PAT I E N T S P O T L I G H T: M E G A N C U R R A N © DESERET NEWS PUBLISHING COMPANY MEGAN CURRAN WITH HCI RADIATION TECHNICIAN JESSICA KELLY, JUST BEFORE MEGAN’S LAST RADIATION TREATMENT AT THE SOUTH JORDAN HEALTH CENTER. ALANA WELM, PHD, AND TRUDY OLIVER, PHD All cancer treatments and medications that are used today were, at one point, part of a clinical trial. Clinical trials can offer hope, particularly in complex diseases such as cancer. But getting access to clinical trials can be difficult, TARGETED THERAPY in cancer treatment is Alana Welm, PhD, an HCI researcher and especially if patients have to travel a long distance to a hospital that often called personalized or precision medicine, associate professor of oncological sciences at offers trials. according to the National Institutes of Health. the University of Utah, led a study on bone loss Targeted therapies are designed to be more effective Clinical trials have very strict reporting and monitoring requirements, which that included patients with cancer. Welm’s team and less harmful than other approaches because the means they are often only available at major medical centers. That’s why discovered a protein that causes bone cells to Huntsman Cancer Institute at the University of Utah recently opened clinical drugs are specially designed to meet the individual become hyperactivated, destroying the bone. The trials to cancer patients at two of its satellite clinics: the South Jordan Health characteristics of each patient. team identified a drug that blocks this protein and Center and the Farmington Health Center. Three Huntsman Cancer Institute (HCI) preserves the bones. They will now test whether Megan Curran, a breast cancer patient and resident of Lehi, was able to researchers made breakthrough discoveries in 2017, blocking this protein in metastatic breast cancer participate in a clinical trial and get her treatments at the South Jordan Health potentially leading to new targeted therapies. patients can protect bones from destruction. Center. This convenience meant more time for Megan to spend with her family and friends. Trudy G. Oliver, PhD, an HCI researcher and Srividya Bhaskara, PhD (pictured on the table associate professor of oncological sciences at the of contents), an HCI researcher and assistant University of Utah, identified new insights in the behavior of small-cell lung cancers. Through professor of radiation oncology at the University of Utah, led a study on a new cancer drug that may “ Care close to home has helped me in so many ways— especially being a single mom. It makes it easier for a family ” that discovery, her team identified a targeted benefit patients with leukemia, a blood cancer. member or a friend to come with me to every treatment. drug combination for tumors that are much Bhaskara focused on two specific proteins that keep more aggressive and faster-spreading. The drug the cancer cells alive. Her team created a targeted Megan Curran combination doubled the survival rate in mice, drug that blocks these proteins, allowing the cancer RESEARCH RESEARCH with similar results in recent human clinical trials. cells to die. The next step is translating these biomarkers to clinical practice. 16 17


  • Page 10

    Bench to Bedside Translational Scholars ADVANCING DISCOVERIES MADE IN THE LAB to medical treatments that can be used in patient care is complex and time-consuming. Commonly called clinical translation, this process can be thought of much like translating something from one language to another. Huntsman Cancer Institute (HCI) makes it a high priority to recruit and mentor top translational physicians from around the world. These physicians take research that begins in HCI laboratories and bring it to the clinical setting, working to improve the lives of our patients. In 2017, HCI honored some of the very best and brightest in our community by designating them Huntsman Translational Scholars. The honor comes with financial support for research to advance discoveries as well as commitment to promote their career development. “ It truly used to be if you had metastatic melanoma ten years ago, there were very few treatments that worked and patients did not live very long. That is now 180 degrees different. ” Robert Andtbacka Howard Colman, MD, PhD PROFESSOR, NEUROSURGERY RESEARCH FOCUS: DEVELOPMENT AND TESTING OF NEW THERAPIES Ignacio Garrido-Laguna, MD, PhD ASSOCIATE PROFESSOR, INTERNAL MEDICINE RESEARCH FOCUS: DEVELOPING TREATMENTS TO IMPROVE OUTCOMES FOR BRAIN TUMORS FOR PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA Robert Andtbacka, MD, CM Adam Cohen, MD, MS Deborah Stephens, DO Theresa Werner, MD RESEARCH RESEARCH ASSOCIATE PROFESSOR, SURGERY ASSISTANT PROFESSOR, INTERNAL MEDICINE ASSISTANT PROFESSOR, INTERNAL MEDICINE ASSOCIATE PROFESSOR, INTERNAL MEDICINE RESEARCH FOCUS: DEVELOPING TECHNIQUES TO IDENTIFY HOW RESEARCH FOCUS: DEVELOPING CLINICAL TRIALS WITH THE RESEARCH FOCUS: DEVELOPING NEW TARGETED THERAPIES FOR RESEARCH FOCUS: CLINICAL TRIALS WITH NOVEL THERAPIES FOR THE MELANOMA SPREADS THROUGH THE LYMPH AND VASCULAR SYSTEMS GOAL OF PERSONALIZING TREATMENT DECISIONS FOR BRAIN PATIENTS WITH LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT OF BREAST AND GYNECOLOGIC CANCERS AND BREAST CANCER 18 19


  • Page 11

    Total Cancer Care: Coming Together to Find Cures A C R I T I C A L PA R T O F T H E C A R E T E A M : A D VA N C E D P R A C T I C E C A R E P R O V I D E R S I love my patients. I’ve been treating some for more than a decade, so in some ways I think of them as family. My wife notices when I get home on Friday, which is my clinic day, I’m usually in a good mood. It’s not because it is the beginning of the weekend, but because I got to spend the day with patients. Working with cancer patients is something I didn’t understand before I came to Huntsman Cancer Institute. But now, I would never go anywhere else, because they are a unique population—they are easy to want to help. One of my patients explained to me that the cancer experience is very personal. When I talk to patients about cancer and their health, it is a very intimate space the patient is trusting me to come into. Dr. Glen Bowen, my mentor, taught me the idea that the treatment team is like an octopus. Meaning, we are a single brain with eight arms. I’m an arm, the nurse is an arm, the scheduler is an arm—we are all an arm, and no arm is more or less important in caring for our patients. RANDY JENSEN, MD, PHD, PROFESSOR OF NEUROSURGERY, AND CHRISTINA RATCLIFF Mark Hyde, PhD, PA-C OUTDOOR ADVENTURE is Christina This study is a partnership among patients, health DIRECTOR OF ADVANCED PRACTICE CLINICIANS Ratcliff’s idea of fun—she enjoys camping, hiking, care providers, and researchers to help accelerate HUNTSMAN CANCER INSTITUTE and road trips with her family and friends. At cancer research and improve patient care. UNIVERSITY OF UTAH HEALTH age 30 after having a seizure, she was diagnosed Since it launched in 2016, more than 4,000 with a brain tumor called anaplastic astrocytoma. participants have enrolled in HCI Total Starting in December 2013, Christina had surgery, radiation, and chemotherapy treatments at Huntsman Cancer Institute (HCI). Cancer Care. The program is borne out of HCI’s participation in the Oncology Research Information Exchange Network (ORIEN), a “ Anyone who participates in a cancer patient’s care is privileged to be in that intimate space with them. ” Mark H yde Christina’s care team, the doctors and researchers group of 17 cancer centers that collaborate to in HCI’s Neuro-Oncology Program, are experts of speed cancer research. international standing. They work together to fit At the participating institutions across the nation, treatments to each individual patient. more than 200,000 patients have signed up. At THE ADVANCED PRACTICE CLINICIANS (APCs) at Huntsman Cancer Institute (HCI) include In January 2015, Christina completed treatment. HCI, about 93% of new patients choose to join. licensed care providers such as nurse practitioner or physician assistant. Educational programs that train PATIENT CARE PATIENT CARE She now visits HCI every six months for follow- That means we enroll more than 400 new patients APCs typically require several years of prior health care experience and at least two years of full-time up care. She also chose to take part in HCI’s Total each month. post-graduate medical education. HCI has invested in APCs, knowing that this group of talented medical Cancer Care study. professionals is a critical link in the cancer care continuum. 20 21


  • Page 12

    High-Tech Equipment and Innovative Therapies B R I N G I N G C U T T I N G - E D G E C A N C E R T R E AT M E N T C L O S E R T O H O M E A STATE-OF-THE-ART CT SCANNER IS ONE OF MANY NEW TECHNOLOGIES AT HCI NEARLY HALF OF ALL CANCER PATIENTS need radiation therapy. Proton therapy is the preferred approach for many childhood and adult cancers, particularly if the tumor is close to a vital YIELDING BETTER IMAGES OF WORKING TO ADVANCE RESEARCH IN organ. Currently, the nearest proton facility is a 10-hour drive from Salt Lake City. But, this new cancer PATIENT TUMORS INNOVATIVE NEW TREATMENT: CAR-T treatment technology is one step closer to reality for the Mountain West, as Huntsman Cancer Institute plans for an Intensity-Modulated Proton Therapy (IMPT) Center to open in the fall of 2020. In 2017, Huntsman Cancer Institute (HCI) was HCI will soon offer a new type of cancer care the first cancer center in the United States to to patients: Chimeric Antigen Receptor therapy use a new, state-of-the-art CT scanner that arms (CAR-T). CAR-T received approval from the radiation oncologists with more information than Food and Drug Administration in 2017. The ever before. Called the Somatom Confidence 64 unique approach shows promise in certain adult from Siemens, this dual-energy scanner is used and childhood cancers. HCI will help advance to help doctors plan for radiation treatments. It creates more detailed images, giving physicians the ability to direct therapy precisely where it is needed. research to better understand this new therapy. TARGETING PROSTATE CANCER WITH “ I really enjoy the strong doctor-patient bond that oncology engenders. When I see my patients in follow-up I know about their NEW MRI-GUIDED BIOPSY families and about their hobbies. We usually DELIVERING HEATED CHEMO MRI-guided biopsy is a new technology recently spend a significant amount of our time just © DESERET NEWS PUBLISHING COMPANY DIRECTLY TO CANCER CELLS New to HCI in 2018, Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is an brought to HCI, and the first in the region. With this test, a radiologist can do a biopsy in an MRI suite and use the MRI to target a specific spot of sort of catching up. ” Jonathan Tward innovative way to deliver heated chemotherapy interest, providing much more accurate results. to cancers in the abdomen. HCI is one of only This procedure is primarily used for patients who PATIENT CARE PATIENT CARE a handful of centers in the country and the only have had multiple negative biopsies despite blood place in the Mountain West region to offer this tests showing high prostate-specific antigen (PSA) Jonathan Tward, MD, PhD unique service. levels, which can indicate cancer. ASSOCIATE PROFESSOR, RADIATION ONCOLOGY 22 23


  • Page 13

    Training the Next Generation OVER THE YEARS, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute (HCI) faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work. More students than ever before are choosing Utah as the place to advance their knowledge. Anna M. Eiring, PhD POSTDOCTORAL FELLOW, WORKING TOWARD ESTABLISHING AN INDEPENDENT LABORATORY “ What makes HCI so special for students studying cancer is the spirit of collaboration that serves a singular Jingtao Guo PHD CANDIDATE Andreana N. Holowatyj, PhD Swapna A. Gudipaty, PhD Gurkan Mollaoglu, MSc mission: to care for those suffering “I chose Utah because of the POSTDOCTORAL FELLOW, FORMER POSTDOCTORAL PHD CANDIDATE from cancer and find innovative ways ” great science as well as the RESEARCHING YOUNG-ONSET FELLOW, NOW HCI RESEARCH interdisciplinary graduate program COLORECTAL CANCER ASSOCIATE “Huntsman Cancer Institute stands to eradicate the disease. as a world-class cancer research that allows students to explore center. It is a great opportunity to G. Weldon Gilcrease EDUCATION AND RECRUITMENT EDUCATION AND RECRUITMENT what they are really interested in.” be a trainee here surrounded by Andy Hahn, MD INTERNAL MEDICINE RESIDENT, brilliant and inspiring scientists. My Aria Vaishnavi, PhD colleagues, both seniors and peers, TRAINING TO BECOME AN ONCOLOGIST POSTDOCTORAL FELLOW, have been very supportive, and I RESEARCHING LUNG CANCER “I have always wanted to train close G. Weldon Gilcrease, MD learn something new from them to mountains, and I was impressed every day.” ASSISTANT PROFESSOR, MEDICINE with how personable and outgoing Fiorella Iglesias Cárdenas, MD people in Utah were. Having a DIRECTOR, HEMATOLOGY/ONCOLOGY (pictured on the table of contents) prestigious cancer research institute FELLOWSHIP PROGRAM PEDIATRIC HEMATOLOGY-ONCOLOGY FELLOW like HCI made choosing Utah easy.” 24 25


  • Page 14

    Recruiting the Best and Brightest Minds in Cancer EXTERNAL ADVISORY BOARD Edward J. Benz, MD PRESIDENT AND CEO EMERITUS DANA-FARBER CANCER INSTITUTE RICHARD AND SUSAN SMITH DISTINGUISHED PROFESSOR OF MEDICINE PROFESSOR, PEDIATRICS AND GENETICS HARVARD MEDICAL SCHOOL Elizabeth H. Blackburn, PhD NOBEL LAUREATE IRWIN M. JACOBS PRESIDENTIAL CHAIR PRESIDENT, THE SALK INSTITUTE FOR BIOLOGICAL STUDIES Michael Caligiuri, MD PRESIDENT, NATIONAL MEDICAL CENTER AND PHYSICIAN-IN-CHIEF, CITY OF HOPE Brian Druker, MD 0000C CHANGING THE DNA OF CANCER CARE DIRECTOR, OSHU KNIGHT CANCER CENTER ASSOCIATE DEAN, ONCOLOGY OSHU SCHOOL OF MEDICINE JELD-WEN CHAIR OF LEUKEMIA RESEARCH INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE OREGON HEALTH AND SCIENCE UNIVERSITY Help drive research SAMUEL CHESHIER, MD, PHD, AND BEN MYERS, PHD, BOTH PREVIOUSLY AT STANFORD UNIVERSITY, JOINED HCI IN 2017. Rob DuWors, MPA DEPUTY DIRECTOR, ADMINISTRATION AND PLANNING even faster. EACH YEAR, HUNTSMAN CANCER INSTITUTE (HCI) recruits new physicians and researchers to JONSSON COMPREHENSIVE CANCER CENTER join our teams at the University of Utah. These faculty come from prestigious institutions across the globe UNIVERSITY OF CALIFORNIA AT LOS ANGELES Show our community you help to be part of our world-renowned research and clinical care programs. With the opening of the Primary Children’s and Families’ Cancer Research Center in 2017, HCI plans to recruit 30-40 new research teams in Elaine Fuchs, PhD REBECCA C. LANCEFIELD PROFESSOR, fund cutting-edge science with a the next five years. This will add even more depth as we work to understand cancer from its beginnings and MAMMALIAN CELL BIOLOGY AND DEVELOPMENT INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE Huntsman Cancer Institute use that knowledge to create and improve cancer treatments. THE ROCKEFELLER UNIVERSITY specialty license plate. NEW FACULTY Ernest T. Hawk, MD, MPH VICE PRESIDENT AND DIVISION CHIEF FOR CANCER Richard Cannon, MD ASSISTANT PROFESSOR, SURGERY INTERESTS: ADVANCED TECHNIQUES FOR Mei Koh, PhD ASSISTANT PROFESSOR, PHARMACOLOGY AND TOXICOLOGY Benjamin Myers, PhD ASSISTANT PROFESSOR, ONCOLOGICAL SCIENCES PREVENTION AND POPULATION SCIENCES BOONE PICKENS DISTINGUISHED CHAIR FOR EARLY PREVENTION OF CANCER of fun 100% HERE’S HOW ds canc raised go HEAD AND NECK CANCER SURGERY INTERESTS: KIDNEY AND LIVER CANCERS, INTERESTS: CELL SIGNALING IN NORMAL THE UNIVERSITY OF TEXAS INCLUDING CHANGES THAT PROMOTE HUMAN DEVELOPMENT AND IN CANCER er res t earch o MD ANDERSON CANCER CENTER Samuel Cheshier, MD, PhD PROGRESSION AND THERAPY RESISTANCE ASSOCIATE PROFESSOR, NEUROSURGERY Mary Playdon, PhD, MPH Timothy R. Rebbeck, PhD 1. Go to dmv.utah.gov. INTERESTS: PEDIATRIC NEUROSURGERY Alvin Kwok, MD, MPH ASSISTANT PROFESSOR, NUTRITION AND AND IMMUNOTHERAPY TECHNIQUES FOR ASSISTANT PROFESSOR, SURGERY INTEGRATIVE PHYSIOLOGY PROFESSOR, EPIDEMIOLOGY HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH PEDIATRIC BRAIN TUMORS INTERESTS: BREAST RECONSTRUCTION AFTER CANCER SURGERY AND IMPROVED OUTCOMES INTERESTS: NUTRITION AND SURVIVORSHIP IN BREAST, OVARIAN, 2. Click Special Group Plates. PROFESSOR OF MEDICAL ONCOLOGY Benjamin Haaland, PhD AND ENDOMETRIAL CANCERS DANA-FARBER CANCER INSTITUTE ASSOCIATE PROFESSOR, POPULATION Laura Lambert, MD 3. Select Cancer Research, John Stringham, MD EDUCATION AND RECRUITMENT HEALTH SCIENCES PROFESSOR, SURGERY Thomas Sellers, PhD, MPH INTERESTS: BIOSTATISTICS TO DESIGN AND INTERESTS: ABDOMINAL CANCER SURGERY, ASSISTANT PROFESSOR, SURGERY CENTER DIRECTOR AND EXECUTIVE VICE PRESIDENT then follow the instructions. INFORM DECISION-MAKING IN CANCER CARE INCLUDING HYPERTHERMIC INTRAPERITONEAL INTERESTS: MINIMALLY INVASIVE LUNG DISTINGUISHED MOFFITT SCHOLAR CHEMOPERFUSION (HIPEC) CANCER SURGERY AND SURGERY FOR MOFFITT CANCER CENTER AND RESEARCH INSTITUTE Sheetal Hardikar, PhD PATIENTS WITH LUNG FAILURE 4. Invite your family and friends to help ASSISTANT PROFESSOR, POPULATION Kathryn Maurer, MD drive cancer research. HEALTH SCIENCES ASSISTANT PROFESSOR, OBSTETRICS Benjamin Voorhies, MD Sandra M. Swain, MD GIVING INTERESTS: MOLECULAR AND GENETIC AND GYNECOLOGY INSTRUCTOR, INTERNAL MEDICINE ASSOCIATE DEAN FOR RESEARCH DEVELOPMENT BIOMARKERS FOR RISK AND PROGNOSIS OF INTERESTS: GYNECOLOGIC CANCERS, INTERESTS: NEW THERAPIES TO TREAT PROFESSOR, MEDICINE GASTROINTESTINAL CANCERS INCLUDING HEREDITARY TYPES MELANOMA AND OTHER CANCERS GEORGETOWN UNIVERSITY MEDICAL CENTER 26 27


  • Page 15

    Determined to Make a Difference Personal and Company Commitment Rich Linton, founder and CEO of the information technology company VLCM, values giving and has brought that to his organization. In 2007, VLCM held its first “United Against Cancer” charity golf tournament. Since then, all proceeds have supported charitable causes, including HCI. With the formation of the VLCM Foundation in 2013, all funds from this event have been donated to Huntsman Cancer Foundation. Josh Linton, Rich’s son, knows firsthand what it’s like to be touched by cancer. His late wife battled melanoma for almost eight years. Josh says, “If you have to go through this challenge, I would want everybody to have Huntsman Cancer Institute on their side. In the end, we couldn’t beat it, but the opportunities we had to fight were because of that work and research.” Over the last 10 years, VLCM has contributed nearly $1 million to research at HCI, with more than $130,000 THE “UNITED AGAINST CANCER” GOLF TOURNAMENT in 2017 alone. RAISES FUNDS FOR HCI RESEARCH. ALANA WELM, PHD, THE THOMAS SISTERS (ALSO KNOWN AS THE IV MAIDENS), AND HUNTSMAN CANCER FOUNDATION’S LOREN SAVAGE Seeding the Next New Breakthroughs Honoring a Grandson with Cancer At Huntsman Cancer Institute (HCI), our Wynn and Christine Tate, big believers in the work of donors are inspired to give and we are inspired HCI, made a generous gift in 2017, offering to match by our donors. Their giving will seed the next individual donations made in the month of December new breakthroughs in cancer research leading to up to $250,000. Nearly a year before, brain cancer took life-saving treatments and, ultimately, eradicate the life of their 20-month-old grandson, Hayes. Inspired cancer altogether. by Hayes and the family he left behind, the Tates are determined to make a difference. They named The Hayes Kyle Tate Memorial Atrium in HCI’s Primary Children’s The IV (“Four”) Maidens SANDRA SCHERER OF THE ALANA WELM LAB AND 12-YEAR-OLD MIKA and Families’ Cancer Research Center to honor him. The IV Maidens Fund, led by Chairwoman “Almost all of us know someone who lost their life to Mika, age 12, presented a check for more than impact people with cancer. When presenting the cancer,” Wynn says. “In memory of our grandson, Hayes, $1,000 to Alana Welm, PhD, to further breast check to Dr. Welm, Mika said, “We are delighted Christine and I are honored to support an organization cancer research. Mika’s sisters—the other three to present our donation to support cancer that means so much to us and makes a difference in the maidens, Ember, Maren, and Dagny (ages 10, research. We hope HCI has continuing success in lives of so many.” 7, and 5, respectively)—were also on hand to fighting cancer with less toxic treatments.” The present the check. The Maidens toured Dr. girls were inspired to donate to HCI in honor of The Tates hope that Hayes’s legacy will accelerate research GIVING GIVING Welm’s lab and received an in-depth look at what their dear friend, who is currently in treatment toward a cure so that one day, children will no longer be WYNN AND CHRISTINE TATE’S LATE GRANDSON, HAYES goes on there, including how their gift will for cancer. taken by this disease. 28 29


  • Page 16

    Highlights From 2017 At a Glance HCI CEO AND DIRECTOR MARY Opened $173 MILLION A GIVEN DAY AT HCI BECKERLE, PHD, testified before the U.S. House of Representatives Committee major expansion: PRIMARY CHILDREN’S AND 400 outpatient 17 surgeries FAMILIES’ CANCER RESEARCH CENTER appointments on Oversight and Government Reform on *including financing costs 91 radiation March 29, 2017. Beckerle spoke about the impact of federally funded cancer research. 76 inpatients treatments >1 million INDIVIDUAL 91 infusion treatments 162 radiology procedures DONORS and a PATIENT CARE $120 MILLION gift from the Huntsman family 4,600 new cancers diagnosed at HCI each year 1,200 genetic counseling consultations yearly Now nearly 1 MILLION MRS. CÁNDIDA MONTILLA DE >23,700 patient visits to HCI’s Wellness and MEDINA, First Lady of the Dominican Republic, and her delegation visited HCI August 10, 2017. They toured HCI and SQUARE FEET of research and care space and Integrative Health Center 125,000 average yearly outpatient visits met with physicians and researchers to learn about HCI’s mission. 1 LINEAR MILE OF LABS TOP 1 percentile nationally in patient satisfaction Part of University of Utah Health, recognized >$120.7 MILLION by Vizient as Top 10 in Quality 2009-2017 in funding for research across the cancer center EDUCATION AND OUTREACH Provide information to >11,000 people yearly through HCI’s Cancer Learning Center EACH YEAR, THE SUNDANCE FILM 200 CLINICAL Reach >100,000 people through community FESTIVAL takes place in Park City, Utah, approximately 30 miles from HCI’s headquarters. The event draws international TRIALS open at any given time health events yearly news coverage, major celebrities, and FACULTY AND STAFF thousands of tourists. In town during Sundance in January 2017, actors Jeremy >450 CANCER RESEARCH >1,800 faculty and staff Renner and Elizabeth Olsen spent two hours at HCI to visit with cancer patients PROJECTS underway each year 183 volunteers giving >16,000 hours yearly and staff. by 170 TEAMS from GIVING GIVING Cancer training to 350 students yearly 30 >20 UofU departments 31


  • Page 17

    Becker’s Hospital Review 1with00 Hospital and Health Systems great oncology programs


  • Page 18

  • View More

Get the full picture and Receive alerts on lawsuits, news articles, publications and more!